Avanos Medical (AVNS) Invested Capital (2013 - 2026)

Avanos Medical's Invested Capital history runs 14 years deep, the most recent figure standing at $869.4 million for Q1 2026.

• In Q1 2026, Invested Capital fell 7.25% year-over-year to $869.4 million; the TTM figure through Mar 2026 stood at $869.4 million (down 7.25% YoY), while the FY2025 annual figure was $868.5 million, up 3202.28% from the prior year.
• Invested Capital came in at $869.4 million for Q1 2026 at Avanos Medical, roughly flat from $868.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.9 billion in Q1 2022 to a low of -$149.1 million in Q2 2024.
• A 5-year average of $865.1 million and a median of $871.4 million in 2025 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital plunged 212.27% in 2024 and surged 3202.28% in 2025, its largest moves.
• Avanos Medical's Invested Capital stood at $1.5 billion in 2022, then declined by 8.03% to $1.4 billion in 2023, then slumped by 98.12% to $26.3 million in 2024, then soared by 3202.28% to $868.5 million in 2025, then increased by 0.1% to $869.4 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $869.4 million, $868.5 million, and $871.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison